Login to Your Account



Pediatric drug guidance similar to U.S., but doesn't encourage innovation

By Shannon Ellis
Staff Writer

Tuesday, July 1, 2014
SHANGHAI – Six Chinese government agencies with authority over health matters, including the CFDA and the National Health and Family Planning Commission, have issued a joint opinion on pediatric drugs in an attempt to address the problem of medicine safety for children in China.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription